A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants without Type 2 Diabetes who have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1)
Details
Age
Adult
Type of Study
Treatment
Locations
Anschutz Health and Wellness
Outpatient CTRC
Principal Investigator
Daniel Bessesen, MD
Study ID
Protocol Number: 23-0833
More information available at ClinicalTrials.gov: NCT05929066
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers